You wouldn't build a precision instrument with rusty tools, and you shouldn't handle high-purity peptides without the right supplies
This hindbrain feeding circuit is often referred to as an aversive pathway since activating CCK-expressing NTS neurons [64] and CGRP-expressing lPBN neurons [63] causes aversion, with the latter being required for the aversive effects of systemic lithium chloride (LiCl) in mice [65]
Yu W, Tang J, Gao C, Zheng X, Zhu P
Issues and prospects With the deepening of the research, ferroptosis has been found in the pathophysiological processes of more and more diseases, and it provides a new method for treating these diseases
Phase 2 Trial Design Participants: 338 adults with obesity (BMI 30) or overweight with comorbidities (BMI 27), without diabetes Duration: 48 weeks Dosing groups: Placebo, 1mg, 4mg, 8mg, or 12mg weekly (with gradual dose escalation over 20-24 weeks) Primary endpoint: Percentage change in body weight from baseline Beyond Weight Loss: Metabolic Improvements Beyond weight loss, the 12mg dose also improved several cardiometabolic markers: Blood pressure: Systolic BP decreased by 7.4 mmHg (clinically significant reduction) Lipids: Triglycerides fell 30%, HDL cholesterol increased 8% Glucose control: HbA1c decreased 0.4% even in participants without diabetes Liver health: Markers of fatty liver disease (ALT, AST) improved significantly Inflammation: C-reactive protein (CRP) decreased, indicating reduced systemic inflammation What this means: Retatrutide appears to improve the metabolic dysfunction behind obesity-related diseases, not just the weight itself
